Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
April 21 (Reuters) - Elicera Therapeutics AB ELIC.ST: ELICERA THERAPEUTICS CARRIES OUT A RIGHTS ISSUE OF APPROXIMATELY SEK 73 MILLION SUBSCRIPTION PERIOD FOR RIGHTS ISSUE RUNS FROM 15 MAY TO 29 MAY 2026 SECURED AMOUNT EXPECTED TO FINANCE OPERATIONS UNTIL END OF 2028 SUBSCRIPTION PRICE IN RIGHTS ISSUE IS SEK 3.0 PER SHARE RIGHTS ISSUE COMPRISES A MAXIMUM OF 24,267,772 NEW SHARES Source text: ID:nWkrbtP0rL Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application